无锡帕母医疗技术有限公司 Mediaroom

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

SHANGHAI, Jan. 2, 2024 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pionee...

2024-01-02 20:30 1732

Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

SHANGHAI, March 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platfor...

2023-03-28 20:30 1432

Pulnovo Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment

SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform...

2023-02-28 10:19 1509

Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board

SHANGHAI, Jan. 14, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform...

2023-01-14 22:00 3453

Pulnovo Medical Announces Dr. Mingdong Zhang, Former FDA Medical Device Officer Joins Scientific Advisory Board

SHANGHAI, Jan. 4, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform,...

2023-01-04 10:46 1963

Pulnovo Medical will be attending JPM Healthcare Conference 2023

SHANGHAI, Dec. 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-12-24 20:00 3711

Pulnovo Medical Inhales Tens of Millions Dollars Funding to Accelerate Global Growth

SHANGHAI, Nov. 7, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM (From Ope...

2022-11-07 20:30 2311

TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH)

SHANGHAI, Sept. 23, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platfor...

2022-09-23 20:30 1839

TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH)

Pulnovo Medical Released Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH)

SHANGHAI, Sept. 20, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platfor...

2022-09-20 20:30 1867

Pulnovo Medical Concludes Successfully the First Steering Committee Meeting

SHANGHAI, Sept. 8, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-09-08 20:30 1213

Pulnovo Medical Concludes Successfully the First Steering Committee Meeting

Pulnovo Medical Limited's PADN Technology Included in 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of PH

SHANGHAI, Sept. 7, 2022 /PRNewswire/ -- A globally recognized OTM innovative platform Pulnovo Medic...

2022-09-07 20:30 2809

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

SHANGHAI, July 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pione...

2022-07-15 20:30 4577

Pulnovo Medical Announces Dr. Krishna Sudhir Joins Scientific Advisory Board

SHANGHAI, June 15, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovati...

2022-06-15 10:00 2323

SCAI & CBS Pulmonary Hypertension Masterclass 2022: Based on Global Perspectives Focusing on New Breakthroughs

SHANGHAI, May 24, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovativ...

2022-05-24 08:30 1994

Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO

SHANGHAI, March 10, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM innovat...

2022-03-10 20:00 2155

Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO

Pulnovo Medical Announced Results From PADN-CFDA Pivotal Trial For The Treatment Of Pulmonary Arterial Hypertension (PAH) Meet The Efficacy Primary Endpoint

SHANGHAI, Jan. 1, 2022 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized device pionee...

2022-01-01 20:30 2547

Latest News